Johnson & Johnson (NYSE: JNJ) VP records 4,075-share option exercise and sale

Rhea-AI Filing Summary

Johnson & Johnson executive Robert J. Decker, VP Corporate Controller, exercised employee stock options for 4,075 shares of common stock on February 27, 2026 and immediately received those shares at an exercise price of $115.67 per share. He then sold 4,075 shares of common stock the same day in an open-market transaction at an average price of $247.87 per share, leaving him with 23,682 shares of common stock held directly.

In addition to his direct holdings, Decker is reported as having 134 shares of common stock held indirectly through an ESOP under the Johnson & Johnson Savings Plan and 646 shares held indirectly through a 401(k) plan, both as of the plans’ most recent reporting date of February 28, 2026.

Insider Trade Summary

Net Seller: 4,075 shares ($1,010,070)

Net Sell 5 txns

Insider Decker Robert J

Role VP Corporate Controller

Sold 4,075 shs ($1.01M)

Type	Security	Shares	Price	Value
Exercise	Employee Stock Options (Right to Buy)	4,075	$0.00	--
Exercise	Common Stock	4,075	$115.67	$471K
Sale	Common Stock	4,075	$247.87	$1.01M
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Options (Right to Buy) — 0 shares (Direct); Common Stock — 27,757 shares (Direct); Common Stock — 134 shares (Indirect, By ESOP)

Footnotes (1)

1. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026). Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026). Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Decker Robert J

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Corporate Controller

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		M		4,075	A	$115.67	27,757	D
Common Stock	02/27/2026		S		4,075	D	$247.87	23,682	D
Common Stock								134(1)	I	By ESOP
Common Stock								646(2)	I	By 401k

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	$115.67	02/27/2026		M			4,075	02/13/2020(3)	02/13/2027	Common Stock	4,075	$0	0	D

Explanation of Responses:

1. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026).

2. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026).

3. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Robert J. Decker	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did JNJ executive Robert J. Decker report?

Robert J. Decker reported exercising 4,075 employee stock options and receiving 4,075 Johnson & Johnson common shares, then selling 4,075 common shares in an open-market transaction on February 27, 2026, according to the Form 4 insider trading disclosure.

At what prices did Robert J. Decker exercise and sell JNJ shares?

Decker exercised stock options to acquire 4,075 Johnson & Johnson shares at an exercise price of $115.67 per share, then sold 4,075 common shares at an average price of $247.87 per share in an open-market transaction on February 27, 2026.

How many JNJ shares does Robert J. Decker hold after the reported transactions?

After the reported transactions, Decker holds 23,682 Johnson & Johnson common shares directly. He also has indirect holdings of 134 shares through an ESOP and 646 shares through a 401(k) plan, based on the plans’ most recent reporting date of February 28, 2026.

What types of securities were involved in Robert J. Decker’s JNJ Form 4 filing?

The filing shows employee stock options, described as a right to buy Johnson & Johnson stock, and common stock. Decker exercised 4,075 options, received 4,075 common shares, and then sold 4,075 common shares in an open-market transaction on February 27, 2026.

What role does Robert J. Decker hold at Johnson & Johnson in this Form 4?

In the Form 4, Robert J. Decker is identified as an officer of Johnson & Johnson, serving as Vice President and Corporate Controller. The reported transactions reflect his personal direct holdings and indirect holdings through retirement and savings plan accounts.